Blood coagulation is initiated by Ca2+-dependent binding of coagulatio
n factor VIIa (FVIIa) to its cofactor, tissue factor(TF), The TF:FVIIa
complex activates factors IX and X, ultimately leading to the formati
on of thrombin and the coagulation of blood. FVII consists of an N-ter
minal gamma-carboxy-glutamic-acid-containing (Gla) domain followed by
two epidermal growth factor (EGF) like domains, the first of which can
bind one Ca2+ ion (K-d approximate to 150 mu M) and a C-terminal seri
ne protease domain. Using H-1 nuclear magnetic resonance spectroscopy,
we have determined the solution structure of a synthetic N-terminal E
GF-like domain (EGF1) of human FVII (residues 45-85) in the absence of
Ca2+. A comparison of this structure of apo EGF1 with the Ca2+-bound
EGF1 in the complex of FVIIa and TF [Banner, D. W., et al. (1996) Natu
re 380, 41-46] suggests that the structural changes in the EGF1 domain
upon Ca2+ binding are minor and are concentrated near the Ca2+-bindin
g site, which is facing away from the TF interaction surface. Amino ac
id side chains that are crucial for the binding of FVII to TF show a s
imilar conformation in both structures and are therefore unlikely to d
irectly influence the Ca2+-dependent binding of FVII to TF. As Ca2+ bi
nding to EGF1 does not lead to a conformational change in the residues
constituting the interaction surface for binding to TF, our results a
re consistent with the idea that the altered orientation between the G
la and EGF1 domains that result from Ca2+ binding is responsible for t
he increased affinity of FVII/FVIIa for TF.